• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名38岁患者的十二指肠梗阻:一例罕见的卵巢癌表现病例报告,需行惠普尔手术。

Duodenal obstruction in a 38-year-old: Case report of an unusual ovarian cancer presentation requiring a Whipple procedure.

作者信息

Somasegar Sahana, Tostrud Lauren, Poultsides George, Renz Malte

机构信息

Department of Obstetrics & Gynecology, Stanford University School of Medicine, Palo Alto, CA, USA.

Section of Surgical Oncology, Department of Surgery, Stanford University School of Medicine, Palo Alto, CA, USA.

出版信息

Heliyon. 2024 Aug 19;10(16):e36581. doi: 10.1016/j.heliyon.2024.e36581. eCollection 2024 Aug 30.

DOI:10.1016/j.heliyon.2024.e36581
PMID:39262961
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11388602/
Abstract

Since ovarian cancer typically spreads intraperitoneally or via lymphatics, a retroperitoneal duodenal obstruction is a rare presentation of ovarian cancer. Such upper gastrointestinal obstruction in a young patient is diagnostically challenging and surgically difficult to address. In this case report, we describe that in an interdisciplinary approach a Whipple pancreaticoduodenectomy could be safely implemented into the interval debulking surgery to achieve complete cytoreduction. No postoperative complications were encountered. The surgical procedure was able to remove the upper gastrointestinal obstruction and thereby the need for a venting gastrostomy tube and total parenteral nutrition and thus provided good quality of life and additional lifetime.

摘要

由于卵巢癌通常通过腹膜内或淋巴管扩散,十二指肠腹膜后梗阻是卵巢癌的一种罕见表现。这种年轻患者的上消化道梗阻在诊断上具有挑战性,手术处理也很困难。在本病例报告中,我们描述了在多学科方法中,胰十二指肠切除术可以安全地纳入间隔减瘤手术以实现完全细胞减灭。未出现术后并发症。该手术能够消除上消化道梗阻,从而避免了放置胃造瘘减压管和全胃肠外营养的需要,因此提供了良好的生活质量和更长的生存期。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd7/11388602/ffa2d926ba63/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd7/11388602/6af8d3105bf2/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd7/11388602/ffa2d926ba63/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd7/11388602/6af8d3105bf2/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7fd7/11388602/ffa2d926ba63/gr1.jpg

相似文献

1
Duodenal obstruction in a 38-year-old: Case report of an unusual ovarian cancer presentation requiring a Whipple procedure.一名38岁患者的十二指肠梗阻:一例罕见的卵巢癌表现病例报告,需行惠普尔手术。
Heliyon. 2024 Aug 19;10(16):e36581. doi: 10.1016/j.heliyon.2024.e36581. eCollection 2024 Aug 30.
2
Successful Management of Upper Gastrointestinal Obstruction With Primary Advanced Ovarian Cancer.原发性晚期卵巢癌致上消化道梗阻的成功管理
Cancer Diagn Progn. 2024 Jul 3;4(4):454-458. doi: 10.21873/cdp.10347. eCollection 2024 Jul-Aug.
3
Primary debulking surgery of the upper abdomen and the diaphragm, with a plasma device surgery system, for advanced ovarian cancer.采用等离子设备手术系统对上腹部和膈肌进行初次肿瘤减灭术,治疗晚期卵巢癌。
Gynecol Oncol. 2017 Jan;144(1):223-224. doi: 10.1016/j.ygyno.2016.10.030. Epub 2016 Nov 9.
4
Pancreaticoduodenectomy in optimal primary cytoreduction of epithelial ovarian cancer: A case report and review of the literature.胰十二指肠切除术用于上皮性卵巢癌的最佳初次细胞减灭术:一例病例报告及文献综述
Gynecol Oncol Rep. 2014 Sep 28;10:25-7. doi: 10.1016/j.gore.2014.09.001. eCollection 2014 Dec.
5
Pancreaticoduodenectomy in high-grade pancreatic and duodenal trauma.胰十二指肠切除术治疗胰腺和十二指肠高位创伤。
Injury. 2024 Sep;55(9):111721. doi: 10.1016/j.injury.2024.111721. Epub 2024 Jul 20.
6
Groove pancreatitis with recurrent duodenal obstruction. Report of a case successfully treated with pylorus-preserving pancreaticoduodenectomy.伴有复发性十二指肠梗阻的沟部胰腺炎。一例保留幽门胰十二指肠切除术成功治疗的病例报告。
Int J Pancreatol. 1997 Apr;21(2):185-8.
7
MIRRORS: a prospective cohort study assessing the feasibility of robotic interval debulking surgery for advanced-stage ovarian cancer.MIRRORS:一项评估机器人间隔减瘤术治疗晚期卵巢癌可行性的前瞻性队列研究。
Int J Gynecol Cancer. 2024 Jun 3;34(6):886-897. doi: 10.1136/ijgc-2024-005265.
8
Case report: Minimally invasive primary debulking surgery for advanced stage epithelial ovarian cancer.病例报告:晚期上皮性卵巢癌的微创初次肿瘤细胞减灭术
Front Oncol. 2024 Feb 2;14:1302724. doi: 10.3389/fonc.2024.1302724. eCollection 2024.
9
To compare the optimal cytoreduction rate in advanced epithelial ovarian cancer stage III/IV after 3 versus 6 cycles of neoadjuvant chemotherapy.比较 3 个与 6 个疗程新辅助化疗后 III/IV 期上皮性卵巢癌的最佳减瘤率。
J Obstet Gynaecol. 2021 May;41(4):616-620. doi: 10.1080/01443615.2020.1787967. Epub 2020 Aug 19.
10
Closed Loop Duodenal Obstruction Secondary to Pancreatic Carcinoma: A Case Report.胰腺癌继发闭环性十二指肠梗阻:一例报告
Comb Chem High Throughput Screen. 2019;22(4):280-286. doi: 10.2174/1386207322666190411112412.

本文引用的文献

1
Niraparib in Patients with Newly Diagnosed Advanced Ovarian Cancer.尼拉帕利治疗新诊断的晚期卵巢癌患者。
N Engl J Med. 2019 Dec 19;381(25):2391-2402. doi: 10.1056/NEJMoa1910962. Epub 2019 Sep 28.
2
Safety and dose modification for patients receiving niraparib.接受尼拉帕利治疗的患者的安全性和剂量调整。
Ann Oncol. 2018 Aug 1;29(8):1784-1792. doi: 10.1093/annonc/mdy181.
3
Clinicopathologic characteristics associated with long-term survival in advanced epithelial ovarian cancer: an NRG Oncology/Gynecologic Oncology Group ancillary data study.
与晚期上皮性卵巢癌长期生存相关的临床病理特征:NRG 肿瘤学/妇科肿瘤学组辅助数据研究。
Gynecol Oncol. 2018 Feb;148(2):275-280. doi: 10.1016/j.ygyno.2017.11.018. Epub 2017 Nov 28.
4
Clinical Significance of CA125 Level after the First Cycle of Chemotherapy on Survival of Patients with Advanced Ovarian Cancer.晚期卵巢癌患者化疗第一周期后CA125水平对生存的临床意义
Yonsei Med J. 2016 May;57(3):580-7. doi: 10.3349/ymj.2016.57.3.580.
5
Pancreaticoduodenectomy in optimal primary cytoreduction of epithelial ovarian cancer: A case report and review of the literature.胰十二指肠切除术用于上皮性卵巢癌的最佳初次细胞减灭术:一例病例报告及文献综述
Gynecol Oncol Rep. 2014 Sep 28;10:25-7. doi: 10.1016/j.gore.2014.09.001. eCollection 2014 Dec.
6
Evolution of surgical treatment paradigms for advanced-stage ovarian cancer: redefining 'optimal' residual disease.晚期卵巢癌外科治疗模式的演变:重新定义“最佳”残余疾病。
Gynecol Oncol. 2012 May;125(2):483-92. doi: 10.1016/j.ygyno.2012.02.024. Epub 2012 Feb 23.
7
The contribution of BRCA1 and BRCA2 to ovarian cancer.BRCA1和BRCA2在卵巢癌中的作用。
Mol Oncol. 2009 Apr;3(2):138-50. doi: 10.1016/j.molonc.2009.02.001. Epub 2009 Feb 10.
8
Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d'Investigateurs Nationaux Pour les Etudes des Cancers de l'Ovaire (GINECO).手术结果作为晚期上皮性卵巢癌预后因素的作用:三项前瞻性随机3期多中心试验的联合探索性分析:由妇科肿瘤学 Arbeitsgemeinschaft 卵巢癌研究小组(AGO-OVAR)和国家卵巢癌研究调查小组(GINECO)开展
Cancer. 2009 Mar 15;115(6):1234-44. doi: 10.1002/cncr.24149.
9
Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study.Ⅲ期上皮性卵巢癌的预后因素:一项妇科肿瘤学组研究
J Clin Oncol. 2007 Aug 20;25(24):3621-7. doi: 10.1200/JCO.2006.10.2517.
10
Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.铂类时代最大程度肿瘤细胞减灭术对晚期卵巢癌的生存影响:一项荟萃分析。
J Clin Oncol. 2002 Mar 1;20(5):1248-59. doi: 10.1200/JCO.2002.20.5.1248.